PharmaCielo Ltd.
PCLOF
$0.06
$0.0114.73%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -32.64% | 176.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -32.64% | 176.92% | |||
| Cost of Revenue | -128.35% | 263.21% | |||
| Gross Profit | 299.67% | -721.41% | |||
| SG&A Expenses | -85.22% | 159.61% | |||
| Depreciation & Amortization | -91.78% | 143.45% | |||
| Other Operating Expenses | -1,857.49% | 74.03% | |||
| Total Operating Expenses | -127.47% | 236.21% | |||
| Operating Income | 159.31% | -262.26% | |||
| Income Before Tax | 129.04% | -7.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 129.04% | -7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 129.04% | -7.01% | |||
| EBIT | 159.31% | -262.26% | |||
| EBITDA | 178.17% | -260.46% | |||
| EPS Basic | 129.63% | -8.00% | |||
| Normalized Basic EPS | 109.62% | -235.48% | |||
| EPS Diluted | 129.63% | -8.00% | |||
| Normalized Diluted EPS | 109.62% | -235.48% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||